Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

By Manenti L.   Paganoni P.   Floriani I.   Landoni F.   Torri V.   Buda A.   Taraboletti G.   Labianca R.   Belotti D.   Giavazzi R.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1948-1956

Elsevier

Access to resources Recommend Favorite

Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results

By Roehe Adriana   Frazzon Ana   Agnes Grasiela   Damin Andrea   Hartman Antonio   Graudenz Marcia  

Breast Cancer Research and Treatment, Vol. 102, Iss. 1, 2007-03 ,pp. : 123-124

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma

By Li He-cheng   Cao Dao-cheng   Liu Yi   Hou Yi-feng   Wu Jiong   Lu Jin-song   Di Gen-hong   Liu Gang   Li Fang-ming   Ou Zhou-luo   Jie Cui   Shen Zhen-zhou   Shao Zhi-ming  

Breast Cancer Research and Treatment, Vol. 88, Iss. 1, 2004-11 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite

Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients

By          

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1567-1572

Spandidos Publications

Access to resources Recommend Favorite

Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer

By Przybylowska Karolina   Kluczna Anita   Zadrozny Marek   Krawczyk Tadeusz   Kulig Andrzej   Rykala Jan   Kolacinska Agnieszka   Morawiec Zbigniew   Drzewoski Jozef   Blasiak Janusz  

Breast Cancer Research and Treatment, Vol. 95, Iss. 1, 2006-01 ,pp. : 65-72

Springer Publishing Company

Access to resources Recommend Favorite